Bing

SEARCH HISTORY

La Jolla Pharmaceutical Co. (LJPC) was a big mover last session, as the company saw its shares rise roughly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent …
Yahoo Finance · 12/15/2014
Explore the tool here. Article printed from InvestorPlace Media, http://investorplace.com/2015/06/6-biotechnology-stocks-to-buy-now-cgix-ljpc-incy-2/.
Investor Place · 6/3/2015
In this article we are going to take a closer look at Tang’s track record and will discuss in detail its top three largest holdings in terms of value, which are represented by Heron Therapeutics Inc (NASDAQ:HRTX), La Jolla Pharmaceutical Company ...
INSIDER MONKEY · 1/29/2015
More from Bing News
Small cap Keryx Biopharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products geared towards addressing unmet needs and providing unique and meaningful advantages to …
Smallcap Network · ByJohn Udovich · 12/2/2014
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of La Jolla Pharmaceutical Co. (LJPC) entered into oversold territory, hitting an RSI reading of 25.6, after changing hands as low as $7.46 per share.
The Street · 10/10/2014
LJPC) on December 11th $11.98. Now look at the price of the stock, it’s up 55% from our buy call and now at $18.60. This is how easy money they made. It’s not yet late, join us at specialpennystockalert.com@gmail.com
Market News Call · 12/19/2014
La Jolla Pharmaceuticals (NASDAQ ... and his observations at the time are an excellent read. Since the March sell-off, LJPC's stock had mostly languished in spite of positive analysts' recommendations. However, by the end of 2014, the stock began a rally ...
Seeking Alpha · 3/24/2015
La Jolla Pharmaceutical Company (NASDAQ:LJPC) operates in a Biotechnology industry. Its balanced short term liquidity position is evident through a quick ratio of 6.30 and no-debt financing. With regards to growth and profitability, La Jolla Pharmaceutical ...
Nautilus Investment Strategies Magazine · 3/10/2014
La Jolla Pharmaceutical (Nasdaq: LJPC) announced the pricing of an underwritten public offering of 15,614,834 units, with each unit consisting of one share of common stock and a warrant to purchase 0.25 shares of common stock, at a price to the public of …
StreetInsider · 5/7/2008
La Jolla Pharmaceutical Company (NASDAQ: LJPC) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at LJPC given that ...
Benzinga · 9/16/2014